Top Markets
#1 Wiki Cat Wiki Cat +55.96%
#2 Siren Siren +35.51%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.62%
#4 Ribbita by Virtuals Ribbita by Virtuals +23.21%
#5 PulseChain PulseChain +18.13%
#6 KUB Coin KUB Coin +17.54%
#7 Velvet Velvet +17.48%
#8 OpenEden OpenEden +16.69%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.55%
#10 The Grays Currency The Grays Currency +16.32%
Coin of the day
Wiki Cat Wiki Cat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
BLIS Technologies Limited BLIS Technologies Limited

BLIS Technologies Limited

BLT
Clasificación en acciones #31240
BLIS Technologies Limited, together with its subsidiaries, specializes in... BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company prominently features several key probiotic strains: BLIS K12, a supplement engineered to bolster ear, nose, and throat well-being in young children, in addition to enhancing immune function and combating halitosis; BLIS M18, an oral probiotic designed to promote robust dental and gum health; and BLIS Q24, a probiotic formulation aimed at harmonizing and rejuvenating the skin's microbiome, thereby fostering healthier, clearer, and more radiant skin. Established in 2000, BLIS Technologies is based in Dunedin, New Zealand, and maintains a global presence with operations spanning New Zealand, the Asia Pacific region, Europe, the Middle East, Africa, and North America.
Precio por acción
$0.01084256
Capitalización bursátil
$13.87M
Cambio (1 día)
0.00%
Cambio (1 año)
1.70%
País
NZ
Comercio BLIS Technologies Limited (BLT)

Categoría

Healthcare
Ingresos de BLIS Technologies Limited (BLT)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de BLIS Technologies Limited, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de BLIS Technologies Limited desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE